$55.37−0.01 (−0.02%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Axogen (AXGN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~15.3%/yr (FY21→FY25), net margin −7.0%. Worth your attention in FY25: Share count (+11.7%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲20.2%
225.2
FY21→FY25CAGR +15.3%/yr
Net income ($M)▼57.6%
−15.7
FY21→FY25CAGR —
Free cash flow ($M)—
−2.9
FY21→FY25CAGR —
Diluted EPS▼47.8%
−0.34
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+11.7%
41.2mn → 46.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$3.7M
+20.8% YoY in FY25 · 1.7% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-7¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 82.0% → 74.3%. Net margin -7.0% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 0.7485, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 266,926.0 | 225,208.0 | 187,338.0 | 159,012.0 | 138,584.0 | 127,358.0 | ▲20.2% | +15.3% |
Cost of revenue | 68,923.0 | 57,855.0 | 45,361.0 | 37,143.0 | 29,775.0 | 22,931.0 | ▲27.5% | +26.0% |
Gross profit | 198,003.0 | 167,353.0 | 141,977.0 | 121,869.0 | 108,809.0 | 104,427.0 | ▲17.9% | +12.5% |
Research & development | 37,432.0 | 32,885.0 | 27,767.0 | 27,339.0 | 25,627.0 | 24,177.0 | ▲18.4% | +8.0% |
Selling, general & admin | 57,344.0 | 44,577.0 | 39,036.0 | 38,412.0 | 40,906.0 | 32,338.0 | ▲14.2% | +8.4% |
Total operating expenses | 211,808.0 | 175,202.0 | 145,264.0 | 143,331.0 | 138,516.0 | 129,843.0 | ▲20.6% | +7.8% |
Operating incomefeeds ROC rank | −13,805.0 | −7,849.0 | −3,287.0 | −21,462.0 | −29,707.0 | −25,416.0 | ▼138.8% | — |
Other income, net | −18,117.0 | −7,854.0 | −6,677.0 | −254.0 | 759.0 | −1,662.0 | — | — |
Pretax income | −31,922.0 | −15,703.0 | −9,964.0 | −21,716.0 | −28,948.0 | −27,078.0 | ▼57.6% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −31,922.0 | −15,703.0 | −9,964.0 | −21,716.0 | −28,948.0 | −26,985.0 | ▼57.6% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.65 | −0.34 | −0.23 | −0.51 | −0.69 | −0.65 | ▼47.8% | — |
Diluted shares (mn) | 61.53 | 46.05 | 44.26 | 42.88 | 42.08 | 41.21 | ▲4.1% | +2.8% |
| Margins | ||||||||
Gross margin67th pct in Healthcare | 74.2% | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% | ▼1.5pp | −7.7pp |
Operating margin | −5.2% | −3.5% | −1.8% | −13.5% | −21.4% | −20.0% | ▼1.7pp | +16.5pp |
Net margin26th pct in Healthcare | −12.0% | −7.0% | −5.3% | −13.7% | −20.9% | −21.2% | ▼1.7pp | +14.2pp |
† TTM = trailing four quarters through 2026-09-30.
5 more years of statements and CSV export are on Premium, and 11 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Axogen's revenue last fiscal year?
Axogen reported revenue of $225.2M in fiscal 2025, up 20.2% from fiscal 2024.
What was Axogen's net income?
Axogen reported net income of −$15.7M in fiscal 2025, a net margin of −7.0%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

